MOBERG PHARMA ANNOUNCES THE FINAL TERMS OF THE RIGHTS ISSUE
STOCKHOLM, 4 August 2023. On 28 June 2023, the Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) announced that the Board of Directors had resolved to, subject to the approval of the Extraordinary General Meeting to be held on 8 August 2023 (the “EGM”), carry out a rights issue of ordinary shares and warrants (“Units”) with preferential rights for existing shareholders in the amount of approximately MSEK 100 before transaction costs (the “Rights Issue”). The Board of Directors of Moberg Pharma today announces the final terms of the Rights Issue.